Undoing Aging News Today

What is aging? We can define aging as a process of accumulation of the damage which is just a side- effect of normal metabolism. While researchers still

DGAP-News: KIZOO Technology Capital GmbH / Key word(s): Financing Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round 07.04.2022 / 13:00 The issuer is solely responsible for the content of this announcement. PRESS RELEASE Kizoo Portfolio Company Elastrin Therapeutics Inc...

DGAP-News: KIZOO Technology Capital GmbH / Key word(s): Financing Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M Seed to Develop Repairing-Based Approaches to Reversing Aging 17.03.2022 / 13:00 The issuer is solely responsible for the content of this announcement. PRESS RELEASE Ki...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation

(0) Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the appointment of Pedro M. Quintana Diez, MD as Chief Medical Officer. Pedro will be responsible for the clinical and regulatory strategy, planning, and execution of the companys clinical development plans. "We are delighted to bring someone with Pedros impressive expertise and experience on board during ...

(1) Elastrin is a biotechnology startup leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again. It is the latest addition to the growing portfolio of Kizoo Technology Capital, a rejuvenation biotech investor focused on reversing age-related damage on a cellular and molecular level. Elastrins lead asset is a nanoparticle conjugated with a novel monoclonal antibody for the treatment of heart valve and vascular calcification. "Elastin fibers a...

$5M financing round led by Kizoo Technology Capital Fresh capital to be employed for productization, to prepare a clinical trial in organ transplantation and to expand cellvies pipeline into rejuvenation therapies Promising initial clinical data generated at Boston Childrens Hospital to be published in the Journal of Thoracic and Cardiovascular Surgery Zurich/Switzerland and Houston/USA, January 25, 2021: cellvie Inc., the leader in Therapeutic Mitochondria Transfer (TMT) and a Harvard Universi...